UMC Utrecht study uncovers 29 novel antibodies against Klebsiella pneumoniae

The Unit­ed King­dom’s Na­tion­al In­sti­tute for Health and Care Ex­cel­lence (NICE) is ask­ing Eli Lil­ly for more da­ta about tirzepatide be­fore it will rec­om­mend the

Pfiz­er ter­mi­nat­ed one of two late-stage tri­als for a sick­le cell treat­ment can­di­date from its $5.4 bil­lion ac­qui­si­tion of Glob­al Blood Ther­a­peu­tics in 2022. The

Mallinck­rodt is con­sid­er­ing fil­ing for Chap­ter 11 bank­rupt­cy for the sec­ond time in three years as it again de­lays mak­ing a pay­ment re­quired as part